Indie Surge: 'Buddy' Banks $3.5M as Five Independents Claim Spots in Top 10

Speciality titles dominated a significant slice of the weekend box office, with five independent films taking positions among the top 10 domestic releases. Deadline’s speciality box office rundown highlights that mix, noting both established holdovers and brand‑new entries contributed to the indie presence. The cluster of indie titles reflects a moment when smaller distributors and niche films are capturing enough audience attention to register alongside bigger mainstream releases. Among those five were both a familiar performer that continued to draw audiences and at least one new arrival making a notable debut in the crowded marketplace.

Roadside Attractions and Saban Films’ original horror‑comedy Buddy proved resilient at the box office, bringing in $3.5 million during the reporting period. Described as a late‑summer hit in trade coverage, Buddy remained a holdover that continued to generate ticket sales after its initial opening window. The film’s continued performance underlines the staying power some speciality pictures can have when they resonate with audiences. The $3.5 million figure positions Buddy as one of the weekend’s stronger indie earners and a key reason independents made such a visible showing in the top 10.

Newcomer Runner was among the independent titles that cracked the top 10 this weekend. Deadline’s report lists Runner as one of the fresh entries contributing to the indie surge, joining holdovers like Buddy to fill out a substantial portion of the chart. While specific grosses for Runner were not detailed in the summary, its inclusion among the five indie top‑10 films signals a noteworthy debut for the title. The film’s presence alongside established speciality performers demonstrates how new, smaller releases continue to find openings to reach audiences amid a competitive theatrical landscape.

A limited L.A. exclusive proved fruitful for If I Go Will They Miss Me, which registered a terrific opening in the Los Angeles market. The trade report singled out the title’s exclusive engagement as a highlight of the weekend’s speciality activity, suggesting the film found a receptive local audience. Exclusive city rollouts like this can help build word‑of‑mouth and create momentum for wider expansion, and the strong L.A. start is a promising sign for the film’s next steps. The summary did not provide box office numbers for the L.A. bow, only that the opening was described as ‘terrific’.

On the documentary front, American Doctor crossed the $400,000 threshold in cumulative grosses, according to Deadline’s weekend accounting. Hitting that milestone marks a solid performance for a documentary in the current theatrical environment, where specialised non‑fiction releases often rely on targeted audiences and festival buzz to drive box office. The $400,000-plus result places American Doctor among the documentary titles that are finding measurable theatrical traction, complementing the narrative and genre films that populated the top 10 indie contingent this weekend.

This weekend’s numbers, as reported, offer a snapshot of an active speciality market in which both holdovers and new releases can make an impact. With five independents in the top 10, including a repeat performer in Buddy and a newcomer in Runner, distributors of niche titles are currently finding room to compete. The presence of a strong L.A. exclusive and a documentary surpassing four‑hundred thousand dollars also points to a diverse set of strategies—city rollouts, genre fare and non‑fiction—that are helping smaller films reach audiences. While the wider theatrical landscape remains competitive, this weekend demonstrated that well‑positioned independent releases can still register meaningful box office results.